Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lead Poisoning | 3 | 2024 | 322 | 2.050 |
Why?
|
Lead | 4 | 2024 | 879 | 1.990 |
Why?
|
Substance Abuse Detection | 3 | 2021 | 301 | 1.810 |
Why?
|
Nucleic Acid Amplification Techniques | 3 | 2020 | 330 | 0.900 |
Why?
|
Pandemics | 11 | 2024 | 8654 | 0.890 |
Why?
|
Chlamydia Infections | 3 | 2021 | 365 | 0.850 |
Why?
|
Antibodies, Bacterial | 2 | 2019 | 1469 | 0.830 |
Why?
|
Gonorrhea | 3 | 2021 | 346 | 0.810 |
Why?
|
Disease Notification | 2 | 2020 | 95 | 0.810 |
Why?
|
Fentanyl | 2 | 2021 | 434 | 0.760 |
Why?
|
Isoantibodies | 1 | 2024 | 674 | 0.720 |
Why?
|
Guillain-Barre Syndrome | 1 | 2022 | 127 | 0.720 |
Why?
|
Rh-Hr Blood-Group System | 1 | 2020 | 63 | 0.710 |
Why?
|
Tick-Borne Diseases | 1 | 2020 | 36 | 0.670 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 463 | 0.670 |
Why?
|
Vitamin D Deficiency | 2 | 2020 | 1388 | 0.650 |
Why?
|
Vaginal Smears | 2 | 2021 | 499 | 0.610 |
Why?
|
Hepatitis C | 3 | 2024 | 1584 | 0.610 |
Why?
|
Coxiella burnetii | 1 | 2018 | 37 | 0.600 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 380 | 0.600 |
Why?
|
Q Fever | 1 | 2018 | 38 | 0.590 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4544 | 0.580 |
Why?
|
Anemia, Hemolytic, Congenital | 1 | 2017 | 71 | 0.580 |
Why?
|
Hydrops Fetalis | 1 | 2017 | 113 | 0.570 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2020 | 384 | 0.550 |
Why?
|
Opioid-Related Disorders | 2 | 2021 | 2164 | 0.530 |
Why?
|
RNA, Viral | 2 | 2024 | 2846 | 0.520 |
Why?
|
Rotavirus Infections | 1 | 2016 | 84 | 0.510 |
Why?
|
United States | 26 | 2024 | 72334 | 0.500 |
Why?
|
Vitamin D | 2 | 2020 | 3303 | 0.490 |
Why?
|
Erythrocytes | 1 | 2024 | 2413 | 0.490 |
Why?
|
Hepatitis B, Chronic | 3 | 2023 | 410 | 0.450 |
Why?
|
Lyme Disease | 1 | 2019 | 631 | 0.420 |
Why?
|
Infection Control | 1 | 2020 | 981 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.410 |
Why?
|
Hepatitis B | 3 | 2022 | 705 | 0.400 |
Why?
|
Residence Characteristics | 1 | 2021 | 2093 | 0.390 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2469 | 0.390 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2021 | 2020 | 0.380 |
Why?
|
Laboratories | 3 | 2020 | 458 | 0.370 |
Why?
|
Workplace | 1 | 2017 | 863 | 0.360 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1386 | 0.360 |
Why?
|
Early Detection of Cancer | 3 | 2021 | 3201 | 0.360 |
Why?
|
Occupational Health | 1 | 2017 | 806 | 0.360 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5840 | 0.350 |
Why?
|
Analgesics, Opioid | 4 | 2020 | 3808 | 0.350 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3156 | 0.340 |
Why?
|
Public Health | 1 | 2023 | 2669 | 0.340 |
Why?
|
Health Status Disparities | 1 | 2020 | 1852 | 0.310 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 1613 | 0.310 |
Why?
|
Neoplasms | 3 | 2022 | 22170 | 0.300 |
Why?
|
Blood Glucose | 1 | 2022 | 6391 | 0.280 |
Why?
|
Guideline Adherence | 1 | 2017 | 2220 | 0.280 |
Why?
|
Environmental Pollutants | 1 | 2016 | 1277 | 0.270 |
Why?
|
Humans | 44 | 2024 | 761504 | 0.270 |
Why?
|
Prevalence | 7 | 2024 | 15732 | 0.270 |
Why?
|
Databases, Factual | 2 | 2020 | 7967 | 0.260 |
Why?
|
Drug Prescriptions | 3 | 2021 | 1670 | 0.260 |
Why?
|
Environmental Exposure | 2 | 2022 | 4486 | 0.260 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1733 | 0.250 |
Why?
|
Female | 30 | 2024 | 392644 | 0.250 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2382 | 0.250 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2015 | 1188 | 0.240 |
Why?
|
Health Promotion | 1 | 2017 | 2214 | 0.240 |
Why?
|
Immunoenzyme Techniques | 2 | 2019 | 1705 | 0.240 |
Why?
|
Hepatitis C Antibodies | 1 | 2024 | 146 | 0.230 |
Why?
|
Erythroblastosis, Fetal | 1 | 2024 | 62 | 0.230 |
Why?
|
Adult | 19 | 2024 | 221177 | 0.230 |
Why?
|
Child, Preschool | 7 | 2024 | 42230 | 0.220 |
Why?
|
Middle Aged | 18 | 2024 | 220895 | 0.220 |
Why?
|
Male | 24 | 2024 | 360804 | 0.220 |
Why?
|
Chlamydia trachomatis | 2 | 2021 | 239 | 0.200 |
Why?
|
G(M1) Ganglioside | 1 | 2022 | 87 | 0.200 |
Why?
|
Infant | 6 | 2024 | 36192 | 0.190 |
Why?
|
Gangliosides | 1 | 2022 | 132 | 0.190 |
Why?
|
Medicaid | 1 | 2015 | 2818 | 0.190 |
Why?
|
Chlamydia | 1 | 2021 | 33 | 0.190 |
Why?
|
Retrospective Studies | 11 | 2022 | 80636 | 0.190 |
Why?
|
Hepacivirus | 3 | 2024 | 1336 | 0.190 |
Why?
|
Neisseria gonorrhoeae | 2 | 2021 | 239 | 0.190 |
Why?
|
Adolescent | 10 | 2024 | 88319 | 0.180 |
Why?
|
Aged | 13 | 2024 | 169289 | 0.180 |
Why?
|
Colorado Tick Fever | 1 | 2020 | 5 | 0.180 |
Why?
|
Blood Grouping and Crossmatching | 1 | 2020 | 100 | 0.180 |
Why?
|
Rocky Mountain Spotted Fever | 1 | 2020 | 19 | 0.170 |
Why?
|
Relapsing Fever | 1 | 2020 | 24 | 0.170 |
Why?
|
Ehrlichiosis | 1 | 2020 | 28 | 0.170 |
Why?
|
Tularemia | 1 | 2020 | 42 | 0.170 |
Why?
|
Anaplasmosis | 1 | 2020 | 37 | 0.170 |
Why?
|
Latent Tuberculosis | 1 | 2022 | 224 | 0.170 |
Why?
|
Babesiosis | 1 | 2020 | 92 | 0.160 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11118 | 0.160 |
Why?
|
Serologic Tests | 1 | 2020 | 381 | 0.160 |
Why?
|
Hepatitis B virus | 4 | 2023 | 528 | 0.150 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26125 | 0.150 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 218 | 0.150 |
Why?
|
Child | 6 | 2024 | 80153 | 0.140 |
Why?
|
Seroepidemiologic Studies | 1 | 2018 | 397 | 0.140 |
Why?
|
Young Adult | 8 | 2020 | 59243 | 0.140 |
Why?
|
Immunity, Herd | 1 | 2016 | 46 | 0.130 |
Why?
|
Rotavirus Vaccines | 1 | 2016 | 62 | 0.130 |
Why?
|
Infant, Newborn | 3 | 2024 | 26198 | 0.130 |
Why?
|
Comorbidity | 2 | 2020 | 10508 | 0.130 |
Why?
|
Rotavirus | 1 | 2016 | 109 | 0.130 |
Why?
|
Urinalysis | 1 | 2017 | 368 | 0.120 |
Why?
|
Sexually Transmitted Diseases | 1 | 2021 | 662 | 0.120 |
Why?
|
District of Columbia | 1 | 2015 | 159 | 0.120 |
Why?
|
Age Distribution | 1 | 2020 | 2880 | 0.120 |
Why?
|
Papillomaviridae | 1 | 2021 | 1119 | 0.120 |
Why?
|
Seasons | 1 | 2020 | 1520 | 0.120 |
Why?
|
Pregnancy | 4 | 2024 | 29874 | 0.110 |
Why?
|
Prenatal Diagnosis | 1 | 2020 | 1265 | 0.110 |
Why?
|
Prostate | 1 | 2021 | 1770 | 0.110 |
Why?
|
Monitoring, Physiologic | 1 | 2020 | 1779 | 0.100 |
Why?
|
Antigens, Viral | 1 | 2016 | 988 | 0.100 |
Why?
|
Blotting, Western | 1 | 2019 | 5035 | 0.100 |
Why?
|
Prescription Drugs | 1 | 2019 | 631 | 0.100 |
Why?
|
Benzodiazepines | 1 | 2017 | 1132 | 0.100 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2020 | 2151 | 0.090 |
Why?
|
Incidence | 2 | 2020 | 21353 | 0.090 |
Why?
|
Regression Analysis | 1 | 2020 | 6343 | 0.090 |
Why?
|
Sexual Behavior | 1 | 2020 | 2180 | 0.090 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2022 | 294 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2015 | 1186 | 0.090 |
Why?
|
Biopsy | 1 | 2021 | 6766 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2017 | 0.080 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1935 | 0.080 |
Why?
|
Odds Ratio | 1 | 2020 | 9646 | 0.080 |
Why?
|
Acute Disease | 1 | 2018 | 7237 | 0.070 |
Why?
|
Medication Adherence | 1 | 2019 | 2176 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4320 | 0.070 |
Why?
|
History, 21st Century | 1 | 2013 | 1567 | 0.070 |
Why?
|
Mass Screening | 2 | 2021 | 5428 | 0.070 |
Why?
|
Health Surveys | 1 | 2016 | 4061 | 0.070 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3415 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58976 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2017 | 3415 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 4420 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6770 | 0.050 |
Why?
|
Chronic Disease | 1 | 2018 | 9318 | 0.050 |
Why?
|
Austria | 1 | 2023 | 207 | 0.050 |
Why?
|
Hepatitis Delta Virus | 1 | 2022 | 24 | 0.050 |
Why?
|
Hepatitis B e Antigens | 1 | 2023 | 133 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7827 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8540 | 0.050 |
Why?
|
Kentucky | 1 | 2020 | 84 | 0.040 |
Why?
|
Mississippi | 1 | 2020 | 95 | 0.040 |
Why?
|
Alabama | 1 | 2020 | 108 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 2023 | 603 | 0.040 |
Why?
|
Hepatitis B Antibodies | 1 | 2020 | 155 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1250 | 0.040 |
Why?
|
Hepatitis B Vaccines | 1 | 2020 | 178 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 39967 | 0.040 |
Why?
|
Cohort Studies | 1 | 2020 | 41487 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8708 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15500 | 0.040 |
Why?
|
Risk Factors | 2 | 2020 | 74206 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2019 | 293 | 0.030 |
Why?
|
DNA, Viral | 1 | 2023 | 2202 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Lipoproteins, HDL | 1 | 2019 | 676 | 0.030 |
Why?
|
Triglycerides | 1 | 2019 | 2461 | 0.020 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2018 | 1351 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.020 |
Why?
|
Logistic Models | 1 | 2019 | 13255 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14031 | 0.010 |
Why?
|
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_